Zobrazeno 1 - 10
of 6 541
pro vyhledávání: '"Hong SHEN"'
Autor:
Hua Shen, Dong Li, Nan Cheng, Lianggang Li, Shiyong Dong, Hong Shen, Lin Zhang, Shengli Jiang
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Aortic valve replacement (AVR) is a critical procedure for patients with aortic valve diseases. This study compares the effectiveness of three minimally-invasive surgical approaches for AVR: totally thoracoscopic (TT), right anterior mini-th
Externí odkaz:
https://doaj.org/article/18ab5d90362144ba9d3986c0b94d524a
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background Platelet dysfunction plays a critical role in the pathogenesis of inflammatory bowel disease (IBD). Despite clinical observations indicating abnormalities in platelet parameters among IBD patients, inconsistencies persist, and the
Externí odkaz:
https://doaj.org/article/eb65a8f45e81474cb8bb85565e1cd0df
Autor:
Yijia Tang, Guangzu Cui, Haicong Liu, Ying Han, Changjing Cai, Ziyang Feng, Hong Shen, Shan Zeng
Publikováno v:
Cancer Communications, Vol 44, Iss 6, Pp 601-636 (2024)
Abstract Significant developments in cancer treatment have been made since the advent of immune therapies. However, there are still some patients with malignant tumors who do not benefit from immunotherapy. Tumors without immunogenicity are called
Externí odkaz:
https://doaj.org/article/2e33b7d665974d8a97d7b1d055c1c3fa
Autor:
Yuankai Shi, Xiaohong Han, Qian Zhao, YuLong Zheng, Jianhua Chen, Xinmin Yu, Jian Fang, Yutao Liu, Dingzhi Huang, Tianshu Liu, Hong Shen, Suxia Luo, Hongsheng Yu, Yu Cao, Xi Zhang, Pei Hu
Publikováno v:
Experimental Hematology & Oncology, Vol 13, Iss 1, Pp 1-12 (2024)
Abstract Background Tunlametinib (HL-085) is a novel, highly selective MEK inhibitor with substantial clinical activities in patients with NRAS-mutant melanoma. This phase I study evaluated the safety and preliminary efficacy of tunlametinib plus vem
Externí odkaz:
https://doaj.org/article/0f192aa657bc4c0d996fc74a75cf28e7
Publikováno v:
Chinese Journal of Lung Cancer, Vol 27, Iss 5, Pp 383-398 (2024)
Malignant pleural mesothelioma (MPM) is a rare cancer with high malignancy and aggressiveness on the pleural, caused by the following risk factors including asbestos inhalation, genetic factors, and genetic mutation. The present chemotherapy, antiang
Externí odkaz:
https://doaj.org/article/7c5665d98bf3447089c0ce01c8983923
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-15 (2024)
Abstract Fluid dynamics computations for tube-like geometries are crucial in biomedical evaluations of vascular and airways fluid dynamics. Physics-Informed Neural Networks (PINNs) have emerged as a promising alternative to traditional computational
Externí odkaz:
https://doaj.org/article/d6a11fb1a3d9485cbc244b448193fcb7
Publikováno v:
Journal of Health, Population and Nutrition, Vol 43, Iss 1, Pp 1-14 (2024)
Highlights The low FODMAP diet is the most recommended dietary intervention for the clinical management of IBS symptoms. Bibliometrics analysis provides a comprehensive perspective and direction on global research trend and hotspot in the low FODMAP
Externí odkaz:
https://doaj.org/article/43a3b3f5c9b64d2788ae0a70fed7778a
Mid-term clinical outcomes of totally endoscopic repair for mitral regurgitation in Barlow’s disease
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 19, Iss 1, Pp 1-6 (2024)
Abstract Objective This study aimed to confirm the safety and feasibility of totally endoscopic repair for mitral regurgitation (MR) in Barlow’s disease. Methods From June 2018 to December 2022, 21 consecutive Barlow’s disease patients (aged 33
Externí odkaz:
https://doaj.org/article/7556436fa50846bcb7e73790153933a3
Publikováno v:
Heliyon, Vol 10, Iss 16, Pp e35479- (2024)
In this study, Ginkgo biloba leave polyprenols (GBP) and polypyridine metal complex were individually utilized as functional ligand and main ligand, four kinds of novel GBP-based polypyridine metal complexes were successfully synthesized and their ce
Externí odkaz:
https://doaj.org/article/30645e46066849a28064a53903c54332
Autor:
Yongfeng Yu, Wen Dong, Yanxia Shi, Rong Wu, Qitao Yu, Feng Ye, Chengzhi Zhou, Xiaorong Dong, Xingya Li, Yongsheng Li, Zhen Li, Lin Wu, Yueyin Pan, Hong Shen, Dehua Wu, Zhongyuan Xu, Jinsheng Wu, Nong Xu, Yanru Qin, Aimin Zang, Jingdong Zhang, Jianya Zhou, Xiaotao Zhang, Yanqiu Zhao, Fugen Li, Huizhen Wang, Qi Liu, Zhenyong Han, Jin Li, Shun Lu
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background: MET overexpression represents the most MET aberration in advanced non-small-cell lung cancer (NSCLC). However, except MET exon 14 ( MET ex14) skipping mutation was recognized as a clinical biomarker, the role of MET overexpression as a pr
Externí odkaz:
https://doaj.org/article/8250df8367a343a395e6e10c30dba4a2